Zhang X - Search Results

1

Molecular Mechanism of Polymyxin Resistance in Multidrug-Resistant Klebsiella pneumoniae and Escherichia coli Isolates from Henan Province, China: A Multicenter Study.

Yan W, Zhang Q, Zhu Y, Jing N, Yuan Y, Zhang Y, Ren S, Hu D, Zhao W, Zhang X, Shi C, Wang M, Li Y. Yan W, et al. Among authors: zhang q, zhang x, zhang y. Infect Drug Resist. 2021 Jul 12;14:2657-2666. doi: 10.2147/IDR.S314490. eCollection 2021. Infect Drug Resist. 2021. PMID: 34285518 Free PMC article.

2

Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations.

Zhang G, Cheng R, Niu Y, Wang H, Yan X, Zhang M, Zhang X, Yang J, Wei C, Ma Z. Zhang G, et al. Among authors: zhang m, zhang x. Zhongguo Fei Ai Za Zhi. 2022 Sep 20;25(9):651-657. doi: 10.3779/j.issn.1009-3419.2022.102.34. Zhongguo Fei Ai Za Zhi. 2022. PMID: 36172729 Free PMC article.

3

Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancer.

Zhang X, Zhang M, Du X, Zhang G, Niu Y, Wei C, Guo L, Shi C, Liu H, Wang H. Zhang X, et al. Among authors: zhang m, zhang g. Front Pharmacol. 2024 Apr 9;15:1331138. doi: 10.3389/fphar.2024.1331138. eCollection 2024. Front Pharmacol. 2024. PMID: 38655174 Free PMC article.

4

Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.

Wang H, Wang Z, Zhang G, Zhang M, Zhang X, Li H, Zheng X, Ma Z. Wang H, et al. Among authors: zhang m, zhang g, zhang x. Cancer Med. 2020 Jan;9(2):487-495. doi: 10.1002/cam4.2706. Epub 2019 Nov 25. Cancer Med. 2020. PMID: 31769228 Free PMC article.

5

The influence of joint application of arsenic trioxide and daunorubicin on primary acute promyelocytic leukaemia cells and apoptosis and blood coagulation of cell strain.

Zhang X, Qin N, Chen X, Guo S. Zhang X, et al. Pak J Pharm Sci. 2015 May;28(3 Suppl):1075-8. Pak J Pharm Sci. 2015. PMID: 26051726

6

[Clinical Efficacy for Treatment of Patients with Peripheral T Cell Lymphoma by HyperCVAD and CHOP/CHOP-like Protocols].

Chen RH, Guo SX, Zhang XJ. Chen RH, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Feb;24(1):80-3. doi: 10.7534/j.issn.1009-2137.2016.01.015. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016. PMID: 26913398 Clinical Trial. Chinese.

7

Efficacy of first-line treatment with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) alone or in combination with chemotherapy for advanced non-small cell lung cancer (NSCLC) with low-abundance mutation.

Yan X, Wang H, Li P, Zhang G, Zhang M, Yang J, Zhang X, Zheng X, Ma Z. Yan X, et al. Among authors: zhang m, zhang g, zhang x. Lung Cancer. 2019 Feb;128:6-12. doi: 10.1016/j.lungcan.2018.12.007. Epub 2018 Dec 6. Lung Cancer. 2019. PMID: 30642455

8

Comparable outcomes of nivolumab in patients with advanced NSCLC presenting with or without brain metastases: a retrospective cohort study.

Zhang G, Cheng R, Wang H, Zhang Y, Yan X, Li P, Zhang M, Zhang X, Yang J, Niu Y, Ma Z. Zhang G, et al. Among authors: zhang m, zhang x, zhang y. Cancer Immunol Immunother. 2020 Mar;69(3):399-405. doi: 10.1007/s00262-019-02462-1. Epub 2020 Jan 6. Cancer Immunol Immunother. 2020. PMID: 31907567 Free PMC article.

9

Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study.

Yan X, Wang Q, Wang H, Li P, Zhang G, Zhang M, Zheng X, Yang J, Zhang X, Ma Z. Yan X, et al. Among authors: zhang m, zhang g, zhang x. J Cancer Res Clin Oncol. 2019 Jan;145(1):235-240. doi: 10.1007/s00432-018-2764-8. Epub 2018 Oct 6. J Cancer Res Clin Oncol. 2019. PMID: 30293117 Free PMC article.

10

Associations between peripheral blood lymphocyte subsets and clinical outcomes in patients with lung cancer treated with immune checkpoint inhibitor.

Li P, Qin P, Fu X, Zhang G, Yan X, Zhang M, Zhang X, Yang J, Wang H, Ma Z. Li P, et al. Among authors: zhang m, zhang g, zhang x. Ann Palliat Med. 2021 Mar;10(3):3039-3049. doi: 10.21037/apm-21-163. Ann Palliat Med. 2021. PMID: 33849094 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168,285 results

Search Page